Growth Hormone as a Treatment for Osteoporosis
Did you know that growth hormone can actually be a possible treatment for osteoporosis? – http://www.thetruthaboutosteoporosis.com
In the U.S. alone, about one-third of adults are obese according to the Centers for Disease Control and Prevention, and this condition is associated with a lot of other medical complications such as diabetes, high blood pressure, cardiovascular diseases, joint mobility problems, asthma, sleep apnea, as well as high blood cholesterol levels.
A previous study done by Dr. Bradella identified that women who had excess abdominal fat were actually at higher risk for bone loss, thus a subsequent study to test if administration of growth hormone can actually help in bone formation and serve as a new treatment for osteoporosis.
A six-month, randomized, placebo-controlled trial was conducted on 79 premenopausal women, who were abdominally obese with an average age of 36 and an average BMI of 35. Each of the women went through an MR spectroscopy exam to undergo evaluation on bone marrow fat. The bone mineral density (BMD) was measured using dual-energy x-ray absorptiometry (DXA). Meanwhile, the thigh muscle area as well as the abdominal fat underwent assessment through computed tomography (CT) scan. Then, baseline information was compared with the follow-up results retrieved after six months to determine if there had been changes.
According to the baseline assessments, 32% of the women had osteopenia, and one woman actually had osteoporosis. The results of the study revealed that after six months, the women who received growth hormone displayed improved bone formation, increased levels of vitamin D, as well as an increase in bone marrow fat and muscle mass. A clear distinction was also noted in that they had much less abdominal fat compared to those in the placebo group. The women who had the highest amount of loss in abdominal fat were those who had improved bone formation the most.
According to Dr. Bredella, “In addition to bone formation, our results also showed that growth hormone increases muscle mass, decreases belly fat and lowers cardiovascular risk markers, such as cholesterol and C-reactive protein.”
She added that the risks for using growth hormone are very minimal and that this therapy could be employed to postmenopausal as well as obese women. Since aging is often linked to a reduction in secretion of human growth hormone, this can serve as a very good potential treatment for postmenopausal osteoporosis.
This study can be very useful in the medical field. The aforementioned results were all beneficial for those who took part in the trial. As noted, the risks associated with using human growth hormone to manage osteoporosis and obesity were very minimal, and therefore didn’t really project a risk when it comes to long-term use. It’s good to know that a safe therapy like this is made available, providing another breakthrough for health promotion.